These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8100065)
1. Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist. Koulu M; Pesonen U; Koskinen S; Scheinin H; Virtanen R; Scheinin M Pharmacol Toxicol; 1993 Mar; 72(3):182-7. PubMed ID: 8100065 [TBL] [Abstract][Full Text] [Related]
2. Chronic dexmedetomidine, a selective alpha 2-agonist, decreases serotonin but not noradrenaline turnover in rat brainstem nuclei. Koulu M; Pesonen U; Virtanen R Eur J Pharmacol; 1990 Feb; 176(2):151-7. PubMed ID: 1690141 [TBL] [Abstract][Full Text] [Related]
3. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin. Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342 [TBL] [Abstract][Full Text] [Related]
4. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat. Pifl C; Pichler L; Kobinger W; Hornykiewicz O Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928 [TBL] [Abstract][Full Text] [Related]
5. Hypothalamic neurochemistry and feeding behavioral responses to clonidine, an alpha-2-agonist, and to trifluoromethylphenylpiperazine, a putative 5-hydroxytryptamine-1B agonist, in genetically obese Zucker rats. Koulu M; Huupponen R; Hänninen H; Pesonen U; Rouru J; Seppälä T Neuroendocrinology; 1990 Nov; 52(5):503-10. PubMed ID: 1980723 [TBL] [Abstract][Full Text] [Related]
6. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist. Rabin BC; Guo TZ; Gregg K; Maze M Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614 [TBL] [Abstract][Full Text] [Related]
7. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo. Sastre-Coll A; Esteban S; García-Sevilla JA Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334 [TBL] [Abstract][Full Text] [Related]
8. Effect of sex and age on brain monoamines and spatial learning in rats. Tanila H; Taira T; Piepponen TP; Honkanen A Neurobiol Aging; 1994; 15(6):733-41. PubMed ID: 7891829 [TBL] [Abstract][Full Text] [Related]
9. Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation. Pertovaara A; Bravo R; Herdegen T Neuroscience; 1993 May; 54(1):117-26. PubMed ID: 8100045 [TBL] [Abstract][Full Text] [Related]
10. The effects of ethanol in combination with the alpha 2-adrenoceptor agonist dexmedetomidine and the alpha 2-adrenoceptor antagonist atipamezole on brain monoamine metabolites and motor performance of mice. Idänpään-Heikkilä JJ; Björn M; Seppälä T Eur J Pharmacol; 1995 Jan; 292(2):191-9. PubMed ID: 7536679 [TBL] [Abstract][Full Text] [Related]
11. The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings. Söderpalm A; Ehrenström F; Söderpalm B J Neural Transm Gen Sect; 1995; 100(3):191-206. PubMed ID: 8748666 [TBL] [Abstract][Full Text] [Related]
12. NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors. Nissbrandt H; Engberg G; Wikström H; Magnusson T; Carlsson A Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):148-61. PubMed ID: 3141816 [TBL] [Abstract][Full Text] [Related]
13. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. de Boer TH; Nefkens F; van Helvoirt A; van Delft AM J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567 [TBL] [Abstract][Full Text] [Related]
14. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra. Nissbrandt H; Engberg G; Pileblad E Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587 [TBL] [Abstract][Full Text] [Related]
15. Effect of BHT 920 on monoaminergic neurons of the rat brain: an electrophysiological in vivo and in vitro study. Seutin V; Scuvée-Moreau J; Giesbers I; Massotte L; Dresse A Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):502-7. PubMed ID: 1982557 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036 [TBL] [Abstract][Full Text] [Related]
17. Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative. MacDonald E; Scheinin H; Scheinin M Eur J Pharmacol; 1988 Dec; 158(1-2):119-27. PubMed ID: 2906007 [TBL] [Abstract][Full Text] [Related]
18. Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. de Villiers AS; Russell VA; Sagvolden T; Searson A; Jaffer A; Taljaard JJ Neurochem Res; 1995 Apr; 20(4):427-33. PubMed ID: 7651580 [TBL] [Abstract][Full Text] [Related]
19. Interactions of alpha 2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test. Durcan MJ; Lister RG; Linnoila M Neuropharmacology; 1989 Mar; 28(3):275-81. PubMed ID: 2566945 [TBL] [Abstract][Full Text] [Related]
20. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats. Treseder SA; Rose S; Jenner P Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]